Source comparison
MK-677 vs Ibutamoren — They're the Same Compound
Here's something that confuses nearly every researcher who orders this peptide for the first time: MK-677 and ibutamoren are not two different compounds you need to choose between. They're the same molecule. The exact same chemical structure. A growth hormone
This comparison does not assign a generated winner or score.
- Here's something that confuses nearly every researcher who orders this peptide for the first time: MK-677 and ibutamoren are not two different compounds you need to choose between. They're the same molecule. The exact same chemical structure. A growth hormone secretagogue that binds to ghrelin receptors in the hypothalamus to stimulate pulsatile GH release without external peptide administration. The naming split happened because pharmaceutical companies assign internal research codes during development (MK-677 was Merck's designation), and sometimes those codes stick even after the generic name (ibutamoren) gets formally assigned by regulatory bodies.
- Our team has fielded this question hundreds of times from researchers evaluating peptide protocols. The confusion is understandable. Online suppliers list both names, research papers use both interchangeably, and nobody explains why. This article covers the naming origin, the mechanism that makes this compound distinct from actual growth hormone or GHRP peptides, and why understanding the receptor pathway matters more than memorising both names.
- What's the difference between MK-677 and ibutamoren?
- There is no difference. MK-677 and ibutamoren are two names for the identical chemical compound (C₂₇H₃₆N₄O₅S). MK-677 was the internal research code assigned by Merck during Phase 2 trials in the 1990s; ibutamoren is the International Nonproprietary Name (INN) assigned later. Both refer to a non-peptide growth hormone secretagogue that mimics ghrelin's action at the GHSR-1a receptor, triggering endogenous GH pulses without suppressing the hypothalamic-pituitary axis the way exogenous GH does.
- The reason both names persist is simple: the research code became so widely used in early literature that even after the INN was formalised, suppliers, researchers, and clinical trial registries continued using MK-677. When you see 'MK 677' listed on a certificate of analysis or referenced in a study abstract, it's the same compound as any product labelled 'ibutamoren mesylate'.